A Study to Evaluate the Efficacy and Safety of AD-203
Status:
Completed
Trial end date:
2020-02-26
Target enrollment:
Participant gender:
Summary
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group
clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the
non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or chronic
gastritis